Dillard's, Inc. (DDS)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 3, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Revenue	6,564	6,590	6,874	6,996	6,624	4,433
Revenue Growth (YoY)	-3.94%	-4.13%	-1.74%	5.62%	49.43%	-30.11%
Cost of Revenue	3,919	3,920	4,031	3,984	3,748	3,069
Gross Profit	2,645	2,671	2,843	3,013	2,877	1,364
Selling, General & Admin	1,771	1,777	1,758	1,705	1,568	1,242
Operating Expenses	1,947	1,955	1,937	1,894	1,767	1,455
Operating Income	698	715.53	905.96	1,119	1,110	-91.33
Interest Expense	-37.68	-37.37	-38.08	-40.84	-42.42	-43.93
Interest & Investment Income	51.16	53.57	45.24	12.83	1.85	0.51
Other Non Operating Income (Expenses)	-3.16	-2.5	-2.56	-2.52	-2.52	-5.68
EBT Excluding Unusual Items	708.32	729.23	910.56	1,088	1,067	-140.44
Gain (Loss) on Sale of Assets	0.27	0.48	6.05	21.05	24.69	-2.23
Asset Writedown	-	-	-	-	-	-10.74
Other Unusual Items	-	-	-	-	-2.83	-
Pretax Income	708.59	729.7	916.62	1,109	1,088	-153.4
Income Tax Expense	131.34	136.23	177.77	217.83	225.89	-81.75
Net Income	577.26	593.48	738.85	891.64	862.47	-71.65
Net Income to Common	577.26	593.48	738.85	891.64	862.47	-71.65
Net Income Growth	-19.53%	-19.68%	-17.14%	3.38%	-	-
Shares Outstanding (Basic)	16	16	17	18	21	23
Shares Outstanding (Diluted)	16	16	17	18	21	23
Shares Change (YoY)	-1.95%	-2.40%	-5.88%	-14.78%	-9.27%	-10.51%
EPS (Basic)	36.07	36.82	44.73	50.81	41.88	-3.16
EPS (Diluted)	36.07	36.82	44.73	50.81	41.88	-3.16
EPS Growth	-17.93%	-17.69%	-11.96%	21.32%	-	-
Free Cash Flow	616.15	609.58	750.65	828.29	1,176	192.49
Free Cash Flow Per Share	38.50	37.81	45.45	47.20	57.09	8.48
Dividend Per Share	1.000	1.000	0.900	0.800	0.700	0.600
Dividend Growth	5.26%	11.11%	12.50%	14.29%	16.67%	20.00%
Gross Margin	40.29%	40.52%	41.36%	43.06%	43.43%	30.77%
Operating Margin	10.63%	10.86%	13.18%	15.99%	16.75%	-2.06%
Profit Margin	8.79%	9.01%	10.75%	12.75%	13.02%	-1.62%
Free Cash Flow Margin	9.39%	9.25%	10.92%	11.84%	17.75%	4.34%
EBITDA	874.23	893.4	1,086	1,307	1,309	122.05
EBITDA Margin	13.32%	13.56%	15.79%	18.69%	19.76%	2.75%
D&A For EBITDA	176.23	177.87	179.57	188.44	199.32	213.38
EBIT	698	715.53	905.96	1,119	1,110	-91.33
EBIT Margin	10.63%	10.86%	13.18%	15.99%	16.75%	-2.06%
Effective Tax Rate	18.54%	18.67%	19.39%	19.63%	20.76%	-
Revenue as Reported	6,564	6,590	6,874	6,996	6,624	4,433
Advertising Expenses	-	36.2	38.1	38.6	32	18.4

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q